Concepedia

Mark Hertzberg

MH

109

Publications

7.6K

Citations

40

H-Index

1992

Active since

Affiliations

Westmead Hospital(Current)

Prince of Wales Hospital

The University of Sydney

Royal North Shore Hospital

The University of Melbourne

Mark Hertzberg is an author at Westmead Hospital specializing in medicine, oncology, and hematology.

ORCID

Top concepts

Publications per year

1992–2024

109

Publications

109

Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Laurie H. Sehn, Alex F. Herrera, Christopher R. Flowers et al. · Journal of Clinical Oncology · 2019 · 741 citations · Full text

Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study

Ian W. Flinn, Richard van der Jagt, Brad S. Kahl et al. · Blood · 2014 · 623 citations · Full text

Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Michael Dickinson, Carmelo Carlo‐Stella, Franck Morschhauser et al. · New England Journal of Medicine · 2022 · 605 citations · Full text

All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4)

Harry Iland, Ken Bradstock, Shane G. Supple et al. · Blood · 2012 · 336 citations · Full text

Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing

David M. Kurtz, Michael R. Green, Scott V. Bratman et al. · Blood · 2015 · 336 citations

Rows per page

1–5 of 109